Boehringer Ingelheim International GmbH - Company Profile
Powered by 
All the data and insights you need on Boehringer Ingelheim International GmbH in one report.
$295
- Save hours of research time and resources with
our up-to-date Boehringer Ingelheim International GmbH Strategy Report
- Understand Boehringer Ingelheim International GmbH position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Boehringer Ingelheim International GmbH patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| EP4058047A1 | Application | NPY2-REZEPTOR-AGONISTEN | A61K38/00; A61K38/22; A61K38/2271; A61P3/00; C07K14/47 | September 21, 2022 |
| AU2021260721A1 | Application | (1,3)diazino(5,4-d)pyrimidines as HER2 inhibitors | A61K47/26; A61K47/32; A61K47/36; A61P35/00; C07D487/04; C07D519/00 | September 15, 2022 |
| WO2022192531A2 | Application | BIOMARKERS ASSOCIATED WITH ANTI-IL-36R ANTIBODY TREATMENT IN GENERALIZED PUSTULAR PSORIASIS | C07K16/2866; C07K2317/24; C12Q1/6869; C12Q1/6883; C12Q2600/106; C12Q2600/136; C12Q2600/158; G01N2800/205; G01N2800/52; G01N33/53; G01N33/564 | September 15, 2022 |
| WO2022191891A1 | Application | SYSTEMS AND METHODS FOR SINGLE PASS COUNTER CURRENT DIAFILTRATION | B01D2313/243; B01D2315/10; B01D2315/16; B01D2319/022; B01D61/145; B01D61/18; B01D63/085; C07K1/34; B01D61/146 | September 15, 2022 |
| AU2021256963A1 | Application | Inhibitors of TRPC6 for treating respiratory conditions | A61K31/444; A61K31/4545; A61K31/496; A61K31/501; A61K45/06; A61P11/00; A61P31/14 | September 15, 2022 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer